All posts by: Michael Zand

About Michael Zand

CRISPR Therapeutics (CRSP) Oral Presentation of New Data on CTX001 at ASH – StreetInsider.com

Continue reading

2017-12-05 NEWS

The Ledger Gazette

CRISPR Therapeutics (CRSP) Oral Presentation of New Data on CTX001 at ASH
StreetInsider.com
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. CRISPR Therapeutics (NASDAQ: CRSP) today announced that Dr. Bill Lundberg, Chief Scientific Officer of CRISPR, is scheduled to present new
What’s Happening To These Stocks? – Vantiv, Inc. (VNTV), CRISPR Therapeutics AG (CRSP)Post Analyst
Crispr Therapeutics (CRSP) Rating Lowered to Hold at BidaskClub …The Ledger Gazette
The Tyler Dylan-Hyde Sells 21639 Shares of Crispr Therapeutics AG (CRSP) StockBangaloreWeekly
HuronReport –Melville Review –Berry Recorder
all 11 news articles »
Continue reading

2017-12-05 NEWS

CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Medicine for β …
GlobeNewswire (press release)
CTX001 is an investigational CRISPR gene-edited therapy for patients suffering from β-thalassemia and sickle cell disease in which a patient’s hematopoietic stem cells are engineered to produce high level of fetal hemoglobin (HbF; hemoglobin F) in red
What’s Happening To These Stocks? – Vantiv, Inc. (VNTV), CRISPR Therapeutics AG (CRSP)Post Analyst
Crispr Therapeutics (CRSP) Rating Lowered to Hold at BidaskClub …The Ledger Gazette
The Tyler Dylan-Hyde Sells 21639 Shares of Crispr Therapeutics AG (CRSP) StockBangaloreWeekly
HuronReport –Street Observer (press release) –Week Herald
all 10 news articles »